IDEAYA Biosciences, Inc. IDYA Operating lease right-of-use asset amortization
Operating lease right-of-use asset amortization at other companies
Other financials
Where this comes from
Reported directly by IDEAYA Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.
The official record: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about IDEAYA Biosciences, Inc.'s operating lease right-of-use asset amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is IDEAYA Biosciences, Inc.'s operating lease right-of-use asset amortization?
- IDEAYA Biosciences, Inc. (IDYA) reported operating lease right-of-use asset amortization of $455K in Q1 2026.
- How has IDEAYA Biosciences, Inc.'s operating lease right-of-use asset amortization changed year-over-year?
- IDEAYA Biosciences, Inc.'s operating lease right-of-use asset amortization decreased by 14.6% year-over-year, from $533K to $455K.
- What is the long-term trend for IDEAYA Biosciences, Inc.'s operating lease right-of-use asset amortization?
- Over 3 years (2022 to 2025), IDEAYA Biosciences, Inc.'s operating lease right-of-use asset amortization has grown at a 10.2% compound annual growth rate (CAGR), from $1.41M to $1.89M.